Elanco Animal Health (ELAN) Cost of Revenue (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Cost of Revenue data on file, last reported at $586.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 15.13% year-over-year to $586.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 10.12% YoY), and the FY2025 full-year result was $2.1 billion, up 5.94% from the prior year.
• Cost of Revenue rose to $586.0 million in Q1 2026, from $555.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $586.0 million in Q1 2026 to a low of $434.0 million in Q2 2023.
• A 5-year average of $503.2 million and a median of $501.0 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue declined 12.16% in 2022 and advanced 15.18% in 2023, its largest moves.
• Tracing ELAN's Cost of Revenue over 5 years: stood at $448.0 million in 2022, then increased by 15.18% to $516.0 million in 2023, then decreased by 2.91% to $501.0 million in 2024, then advanced by 10.78% to $555.0 million in 2025, then grew by 5.59% to $586.0 million in 2026.
• Business Quant data shows ELAN's Cost of Revenue at $586.0 million in Q1 2026, $555.0 million in Q4 2025, and $530.0 million in Q3 2025.